Skip to main content

Vyome Holdings, Inc

HIND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001427570

No open-market purchases or sales by Vyome Holdings, Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $296.5K in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Vyome Holdings, Inc changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of HIND: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders819+2
Shares93.7K12.2K92.0K+10.5K (+12.9%)
Value$322.3K$42.0K$198.3K−$82.1K (−29.3%)

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held Vyome Holdings, Inc at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to HIND in Q1 2026
InstitutionSharesValue% of portfolio
Vanguard Fiduciary Trust Co12,195$26.2K0.00%
Vanguard Capital Management LLC9,463$20.3K0.00%
Tower Research Capital LLC (TRC)1,391$2.99K0.00%
Caitong International Asset Management Co., Ltd2$40.00%

Sold out (2)

Institutions that held Vyome Holdings, Inc at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of HIND in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Millennium Management LLC45,144$155.3K
Bank of America Corp16$55

Not filed for Q1 2026 yet (1)

Institutions that held Vyome Holdings, Inc at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HIND in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc12,195$42.0K